GlassScriptPhysician profile
Aruna Gouru
NPI 1659518793
$587.65
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $94.40 · 2022: $14.70.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $150.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $105.55 | 2019 | |
| Pfizer INC. | $94.83 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $88.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $51.01 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.57 | 2019 | |
| Vifor Pharma, INC. | $24.22 | 2019 | |
| Allergan, INC. | $23.40 | 2019 | |
| Horizon Therapeutics Plc | $17.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aruna Gouru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.